A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2011
12/01/2011	US20110293685 Scaffolds for tissue engineering and regenerative medicine
12/01/2011	US20110293684 Surface-coated structures and methods
12/01/2011	US20110293681 Hand sanitizing patch having an integrally bonded antimicrobial
12/01/2011	US20110293679 Method for coating microspheres onto a flexible material
12/01/2011	US20110293678 Micellarly integrated oxidation protection for natural dyes
12/01/2011	US20110293676 Oral Cephalotaxine Dosage Forms
12/01/2011	US20110293674 MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION
12/01/2011	US20110293673 Oral film-form base and oral film-form preparation
12/01/2011	US20110293672 Pancreatic tumour treatment
12/01/2011	US20110293671 Bacteriophage compositions for treatment of bacterial infections
12/01/2011	US20110293670 Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone
12/01/2011	US20110293669 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293668 Oral odor control method and product
12/01/2011	US20110293667 Bioengineered Tissue Constructs and Methods for Producing and Using Thereof
12/01/2011	US20110293666 Bioengineered Tissue Constructs and Methods for Production and Use
12/01/2011	US20110293647 Immunogenic lhrh compositions and methods relating thereto
12/01/2011	US20110293592 Method of treating coronary arteries with perivascular delivery of therapeutic agents
12/01/2011	US20110293537 formulations with anti-neoplastic activity
12/01/2011	US20110293536 Buccal, polar and non-polar spray containing zolipidem
12/01/2011	US20110293535 Composition for buccal absorption of nicotine for the purpose of smoking cessation
12/01/2011	US20110293534 Aerosol can spray incorporating a nutritional cell scaffold for use as first aid treatment for wounds/burns and for use in cell therapy/tissue repair
12/01/2011	US20110293532 Antiperspirant compositions
12/01/2011	US20110293521 Anti-viral compositions and methods for administration
12/01/2011	US20110293516 Compositions and methods of use of targeting peptides against placenta and adipose tissues
12/01/2011	US20110290694 Oral film dosage form having indicia thereon
12/01/2011	US20110289748 Compositions containing tetrafluoropropene and carbon dioxide
12/01/2011	DE102010021688A1 Verfahren zur Herstellung eines micellaren Wirkstoffkonzentrats A method for producing a micellar drug concentrate
12/01/2011	CA2837129A1 2-iminobiotin formulations and uses thereof
12/01/2011	CA2801020A1 A stable pharmaceutical formulation comprising telmisartan and hydrochlorothiazide
12/01/2011	CA2800968A1 Oral film dosage form having physical-chemical identifier thereon
12/01/2011	CA2800964A1 Oral film dosage form having indicia thereon
12/01/2011	CA2800910A1 Pharmaceutical dosage form containing an antipsychotic agent
12/01/2011	CA2800716A1 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
12/01/2011	CA2800693A1 Delivery of therapeutic agents to inflamed tissues using folate-targeted agents
12/01/2011	CA2800272A1 Removal of serine proteases by treatment with finely divided silicon dioxide
12/01/2011	CA2800253A1 Aqueous formulations for coating microneedle arrays
12/01/2011	CA2800188A1 Stable multi-dose compositions comprising an antibody and a preservative
12/01/2011	CA2800155A1 Method for preparing an enriched igg composition from plasma
12/01/2011	CA2798739A1 Nanocarrier compositions with uncoupled adjuvant
12/01/2011	CA2794868A1 Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition
12/01/2011	CA2794553A1 Topical pharmaceutical compositions comprising mometasone furoate
12/01/2011	CA2794420A1 Injectable emulsion of sedative hypnotic agent
11/2011
11/30/2011	EP2389939A1 Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
11/30/2011	EP2389938A1 Antifungal medicinal compositions
11/30/2011	EP2389935A1 Controlled-Release oral Solution Formulations of Pregabalin
11/30/2011	EP2389934A1 Controlled-Release Tablet Formulations of Pregabalin
11/30/2011	EP2389933A1 Controlled-Release Pregabalin Compositions
11/30/2011	EP2389931A1 Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
11/30/2011	EP2389929A1 Pharmaceutical formulations of tenofovir
11/30/2011	EP2389928A2 Biodegradable polymer encapsulated microsphere particulate film and method of making thereof
11/30/2011	EP2389927A1 Pharmaceutical formulations of rasagiline
11/30/2011	EP2389926A2 Hydrogel implants with varying degrees of crosslinking
11/30/2011	EP2389925A2 Hydrogel implant with varying degrees of crosslinking
11/30/2011	EP2389924A1 An eyedrops of the deproteinized calf blood extract
11/30/2011	EP2389923A1 Stable ready to use injectable paracetamol formulation
11/30/2011	EP2389896A2 Hydrogel implants with varying degrees of crosslinking
11/30/2011	EP2389895A2 Hydrogel implants with varying degrees of crosslinking
11/30/2011	EP2389894A2 Hydrogel implants with varying degrees of crosslinking
11/30/2011	EP2389221A2 Sustained released delivery of one or more agents
11/30/2011	EP2389178A2 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders
11/30/2011	EP2389174A2 Chronotherapeutic pharmaceutical composition
11/30/2011	EP2389172A1 Abuse resistant melt extruded formulation having reduced alcohol interaction
11/30/2011	EP2389170A2 A new coating composition and use thereof
11/30/2011	EP2389169A1 Controlled release formulations with continuous efficacy
11/30/2011	EP2389168A2 Pharmaceutical compositions comprising phosphate-binding polymer
11/30/2011	EP2389167A2 Modified release solid pharmaceutical compositions of trimetazidine and process thereof
11/30/2011	EP2389166A1 Pharmaceutical composition comprising aleglitazar
11/30/2011	EP2389165A2 Pharmaceutical composition of ibandronate sodium salt or a hydrate thereof
11/30/2011	EP2389164A2 Pharmaceutical compositions comprising a hcv polymerase inhibitor prodrug
11/30/2011	EP2389163A1 Controlled release pharmaceutical or food formulation and process for its preparation
11/30/2011	EP2389162A1 Processes for coating a carrier with microparticles
11/30/2011	EP2389161A2 Controlled release systems from polymer blends
11/30/2011	EP2389160A1 Continuous double emulsion process for making microparticles
11/30/2011	EP2389159A1 Process for preparing particles of opioids and compositions produced thereby
11/30/2011	EP2389158A1 Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids
11/30/2011	EP2389157A1 Drug delivery system for use in the treatment of vascular and vessel-related pathologies
11/30/2011	EP2389156A1 Peg-lipid conjugates for increasing the solubility of drug compounds
11/30/2011	EP2389155A2 Orally disintegrating tablets for the treatment of pain
11/30/2011	EP2389070A1 Disintegrable formulations of lanthanum carbonate
11/30/2011	EP2303228B1 Fosphenytoin composition
11/30/2011	EP2197967B1 Coating composition comprising polydextrose, process for preparing same and use for coating ingestible solid forms
11/30/2011	EP2114375B1 Rapidly dispersable, particulate film coating agent based on polyvinyl alcohol-polyether graft copolymers
11/30/2011	EP2089006B1 Medicament with controlled release containing galanthamine
11/30/2011	EP1988863B1 Ring pessary in the uterus
11/30/2011	EP1778186B1 Method for preparation of poly-iclc and uses thereof
11/30/2011	EP1677818B1 Stable aqueous g-csf-containing compositions
11/30/2011	EP1663155B1 Dry powder composition comprising co-jet milled particles for pulmonary inhalation
11/30/2011	EP1521759B1 Metallic object with a nucleic acid coating and method for producing said object
11/30/2011	EP1501496B1 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
11/30/2011	EP1019446B2 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
11/30/2011	CN202052060U 缓痛贴 Relieve pain stickers
11/30/2011	CN202052059U 微孔型透皮贴膜 Transdermal microporous film
11/30/2011	CN202052058U 治疗骨质增生性骨关节病的药贴 Treatment of bone and joint disease osteoarthritis drugs posted
11/30/2011	CN202052057U 具有气囊的贴布 A bladder patch
11/30/2011	CN202052056U 一种防溢胶的外用异形凝胶贴剂 An anti-shaped excess glue topical gel patches
11/30/2011	CN202052055U 一种防挥发滴丸 An anti-volatile Dripping Pills
11/30/2011	CN202052054U 一种盐酸阿霉素缓释结构 One kind of doxorubicin hydrochloride sustained-release structure
11/30/2011	CN1980669B 含喹啉化合物的新组合物 New compositions containing quinoline compound
11/30/2011	CN1961879B 组成石杉碱甲鼻用原位凝胶喷雾剂的药物组合物、其制备方法及用途 Huperzine A composition in situ gel nasal sprays a pharmaceutical composition, methods for their preparation and use
11/30/2011	CN1954872B 一种中药组合物及其制备方法 Chinese medicinal composition and its preparation method

1 ... 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 ... 2991